Target intelligence / Profile preview

Asparagine synthetase (ASNS) (ASNS)

Target
ASNS
Molecular classification
Enzyme
01

Overview

Asparagine synthetase (ASNS) is a cytoplasmic enzyme that catalyzes the ATP-dependent synthesis of asparagine from aspartate and glutamine, producing glutamate as a byproduct. It features two domains: an N-terminal glutaminase domain for glutamine hydrolysis to ammonia and a C-terminal synthetase domain for aspartate activation via β-aspartyl-AMP intermediate, connected by an intramolecular tunnel. Encoded by a single gene on chromosome 7q21.3 in humans, ASNS expression is low basally but upregulated by amino acid response (AAR) and unfolded protein response (UPR) pathways under stress. Elevated ASNS contributes to L-asparaginase resistance in leukemia, and deficiency causes neurological disorders.

Other names
asparagine synthetaseaspartate-ammonia ligaseASNSglutamine-dependent asparagine synthetase
02

Mechanism of action

Inhibition of asparagine synthesis leading to asparagine depletion and cell death in ASNS-dependent cancers; Competitive inhibition with ATP at synthetase active site

03

Biological functions

Amino acid biosynthesisProtein synthesis supportResponse to cellular stress (AAR and UPR pathways)
04

Disease associations

Cancer (leukemia chemotherapy resistance)Neurological disorder (asparagine synthetase deficiency)
05

Safety considerations

Chemotherapy resistance in high-ASNS cancersPotential off-target effects on related AMP-forming enzymes (e.g., NAD synthetase, GMP synthetase)
06

Interacting drugs

L-asparaginase

1 more in the full profile.

07

Biomarkers

ASNS expression levels (high expression linked to L-asparaginase resistance in leukemia)

Beyond the preview

Go deeper on Asparagine synthetase (ASNS) (ASNS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asparagine synthetase (ASNS) (ASNS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call